Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$27.42 - $43.63 $425,010 - $676,265
-15,500 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$36.48 - $52.22 $273,600 - $391,650
-7,500 Reduced 32.61%
15,500 $636,000
Q4 2021

Feb 15, 2022

BUY
$33.11 - $55.01 $215,215 - $357,565
6,500 Added 39.39%
23,000 $1 Million
Q3 2021

Nov 16, 2021

SELL
$50.07 - $66.05 $776,085 - $1.02 Million
-15,500 Reduced 48.44%
16,500 $826,000
Q2 2021

Aug 16, 2021

BUY
$56.61 - $80.46 $860,472 - $1.22 Million
15,200 Added 90.48%
32,000 $2.02 Million
Q1 2021

May 18, 2021

SELL
$86.23 - $125.19 $1.56 Million - $2.27 Million
-18,100 Reduced 51.86%
16,800 $1.56 Million
Q4 2020

Feb 17, 2021

BUY
$79.17 - $111.47 $2.58 Million - $3.63 Million
32,600 Added 1417.39%
34,900 $3.13 Million
Q3 2020

Nov 17, 2020

BUY
$81.91 - $134.94 $188,393 - $310,362
2,300 New
2,300 $238,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $473M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.